Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02303067 · ClinicalTrials.gov registry record
Prospective International Study of Coronary Subtraction Using 320 Detector Row CT (CorSub)
A clinical trial of Coronary Artery Disease, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- 13
- Enrollment target
- 2
- Study locations
NCT02303067 is a study of Coronary Artery Disease that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 13 participants, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT02303067, a study of Coronary Artery Disease, has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
- 2
- Study locations
Study Summary
Background: \- This study is designed for people who need a standard, non-research invasive coronary angiogram to find out if they have heart disease. Researchers want to take a computed tomography (CT) scan of people s hearts before their procedure to see if this less invasive test can also diagnose coronary artery disease. Objectives: \- To learn if a new way to view CT pictures is able to accurately diagnose coronary artery disease. Eligibility: \- People age 55 and older who need a coronary angiogram. Design: * Participants will be screened with their medical records. * Participants may give a blood sample. * Participants may have a CT scan of the heart with and without contrast. The CT scan will not interfere with their medical care. * Participants blood pressure and heart rhythm will be monitored before, during, and after the CT scan. They may have an electrocardiogram. * Before the scan, participants will have an intravenous catheter put into their arm. It will be used to inject contrast. * Participants may take a beta blocker to slow their heart rate. * Participants may take nitroglycerin under their tongue. It will enlarge their heart blood vessels and improve picture quality. It may cause a flushing sensation or headache. * Participants will lie on their back on a padded table. The table slides into a large, donut-shaped machine. An x-ray tube will move around their body, taking pictures. They will be asked to hold their breath for 5 seconds at a time. * Participants will be called 30 days after their angiogram. They will answer questions about their health, hospital visits, or medical treatments.
Conditions Studied
Study Locations (2)
Maryland
- National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda
Other
- Rigshospitalet - Copenhagen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2015-01-06 |
| Est. Completion | 2018-08-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02303067
The ClinicalTrials.gov registry entry for NCT02303067 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (99% lower). The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 0 interventions.
NCT02303067 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Maryland, Other.
Frequently Asked Questions
What is clinical trial NCT02303067 about?
NCT02303067 is a clinical study titled "Prospective International Study of Coronary Subtraction Using 320 Detector Row CT (CorSub)". Background: \- This study is designed for people who need a standard, non-research invasive coronary angiogram to find out if they have heart disease. Researchers want to take a computed tomography (CT) scan of people s hearts before their procedure to see if this less invasive test can also diagno...
What is the current status of trial NCT02303067?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2015-01-06. Estimated completion is 2018-08-13.
What conditions does trial NCT02303067 study?
This clinical trial studies the following conditions: Coronary Artery Disease.
Who is sponsoring clinical trial NCT02303067?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02303067 being conducted?
This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Factors Affect Outcomes in Cardiovascular Surgery
RECRUITING
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
RECRUITING · NA
-
Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.